HEALTH TECHNOLOGY

KLAS and Phreesia Partner to Deliver Patient Insights on Healthcare Technology

KLAS, Phreesia | May 30, 2022

KLAS and Phreesia

KLAS, a healthcare research and insights firm, and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce the release of a report that aims to shed light on patients’ preferences and expectations for the technology they interact with as a part of their healthcare experience. The report is the result of a survey designed to better understand patient sentiments on a range of topics, including how they like to schedule appointments, their participation in telehealth visits and their communication with their doctor.

KLAS and Phreesia partnered together on this report because they share a common mission of improving healthcare and the patient experience, and they recognize that patients’ voices and preferences are not always reflected in healthcare technology. The two organizations leveraged the size and scale of Phreesia’s network—which performed more than 100 million patient check-ins in 2021—to get a firsthand perspective of patients’ priorities.

"What do patients want?" asked Adam Gale, CEO of KLAS Research. "This report, based on a survey with nearly 13,000 patients, provides deep insights into how providers and vendors can help meet patient preferences."

Phreesia surveyed patients across the U.S. over a two-week period in 2021, as they checked in to a doctor’s appointment using Phreesia’s automated intake platform. The quantitative survey asked 14 questions about patients’ experiences using healthcare technology. Respondents represented a wide range of demographic groups across age, education level, race and gender.

The report includes many detailed, data-driven insights and recommendations to providers, including

 

  • Digital access tools are very important to patients: Online appointment self-scheduling and check-in, price transparency and online bill pay are among the offerings patients desire most. Survey responses indicate that patients aged 18-34 are almost twice as likely to choose organizations that have digital access tools.
  • There are gaps between what patients want and what is offered by vendors and provider organizations—for example, the ability to schedule and reschedule an appointment or request a prescription refill online.
  • Patients are still interested in telehealth: Nearly half of respondents had at least one virtual visit in the past year. Of those who did not, 40% reported they are likely to receive care virtually in the future.
  • Only 33% of respondents interact with a provider portal at least once a month, and 26% don’t use a portal at all, with the youngest patients (18-24 years old) most likely to fall into the latter category. The report recommends providers take a multi-pronged approach and offer technology alternatives for things like virtual care and patient communication to better engage those who rarely or never use a portal, in addition to encouraging increased portal adoption.

 

As the report describes, patients want to be more actively involved in their healthcare, especially since the start of the pandemic. We believe that patient-centered care is critical to the transformation of our healthcare system. It’s incredibly important to us to be able to use our insights to help providers better engage patients and improve their experience. We’re thrilled to partner with KLAS on this valuable work.”

Phreesia CEO Chaim Indig

This collaboration is a result of Phreesia and KLAS’ common interest in ensuring patients’ voices are heard and that technology reflects their needs and preferences. As part of the non-financial agreement, KLAS performed its own analysis of Phreesia’s data, created this report and maintains editorial rights. KLAS’ partnership with Phreesia is in no way an endorsement of Phreesia’s performance and has had no impact on Phreesia’s standing in KLAS ratings.

About KLAS

KLAS has been providing accurate, honest, and impartial insights for the healthcare IT (HIT) industry since 1996. The KLAS mission is to improve the world’s healthcare by amplifying the voice of providers and payers. The scope of our research is constantly expanding to best fit market needs as technology becomes increasingly sophisticated. KLAS finds the hard-to-get HIT data by building strong relationships with our payer and provider friends in the industry. Learn more at klasresearch.com.

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.

Spotlight

As they work on the front lines of healthcare, nurses are among the biggest users of information technology. Still, too many are still using suboptimal tools.
 As we've shown here before, RNs can be critical to ensuring electronic health records are used better.
..

Spotlight

As they work on the front lines of healthcare, nurses are among the biggest users of information technology. Still, too many are still using suboptimal tools.
 As we've shown here before, RNs can be critical to ensuring electronic health records are used better.
..

Related News

DIGITAL HEALTHCARE

Commure Introduces New Model to Accelerate Transformation in Healthcare with CommureOS

Commure | November 14, 2022

To help healthcare organizations hurdle long-standing barriers to meaningful transformation and drive exponential innovation at scale, Commure, Inc. today introduced CommureOS, a revolutionary transformation platform purpose-built for healthcare, at HLTH 2022. CommureOS is designed to give healthcare organizations the power to synthesize and maximize their existing solutions as well as easily build and rapidly deploy intelligent workflows to enhance clinical, operational, and financial efficiency. By reconciling information through a single platform and facilitating easy and connected innovation, CommureOS enables hospitals and health systems to streamline their technology experience, empower their healthcare workforce, and enhance care delivery and outcomes. “For decades, health organizations have been pushed to innovate at near-impossible speeds to keep up with the industry’s rate of change — and have made remarkable strides despite it all, More than ever, they deserve a robust tech experience that ensures their progress can endure. Over the past five years, we’ve been quietly and responsibly building a new model of innovation with some of our nation’s biggest health systems — and today, we invite pioneering organizations to embark with us on a new era of healthcare transformation.” -Ashwini Zenooz, MD, CEO of Commure With CommureOS, healthcare organizations can more effectively and efficiently: Unlock and connect disparate data points and static insights across their technology ecosystem and make them actionable and helpful at the point of care. Create, test, and deploy new solutions to solve their unique challenges with modular and industry-native building blocks — turning months of development into hours of configuration. Reuse established clinical and non-clinical data connections and extend across multiple use cases and workflows to seamlessly scale innovation throughout their organization. At a time when hospitals and health systems across the country are grappling with rising burnout and attrition, Commure is steadfast in our commitment to empower the healthcare workforce by simplifying and optimizing the tasks they do and the workflows they use every day, By helping health organizations derive meaning from mountains of data and build connected solutions at scale, we can finally ensure that people — rather than technology — are at the heart of our healthcare ecosystem,said Abhijit Mitra, chief product and engineering officer at Commure. With CommureOS, leading health systems and hospitals have the tools and support to create or customize the organizational workflows they need with ease, enabling them to streamline traditionally manual and time-consuming tasks and cultivate a more dynamic experience for clinicians, staff, and care delivery teams. There’s a new generation of digital health innovators keeping health systems at the center of their own transformation journeys — and Commure is at the forefront, Migrating from point solutions to platform is essential for technology-driven transformation of the sector. By connecting the dots and driving exceptional experiences, Commure is advancing our collective pursuit of responsible and enduring innovation,said Hemant Taneja, CEO and managing director at General Catalyst and co-founder of Commure. About Commure Commure, Inc. is building the first operating system designed for healthcare. By connecting disparate datasets, surfacing meaningful insights, accelerating performance through a suite of intuitive applications, and enabling seamless innovation across the industry, we empower every person in the health ecosystem to deliver exceptional care. Commure’s original applications include solutions to improve staff safety, enhance clinical workflow, and bolster financial operations. Commure is partnering with health systems, payors, and digital innovators to build a vibrant health ecosystem together; currently, the company enables more than 160,000 clinicians and staff across more than 400 care facilities to advance care through collaboration.

Read More

HEALTH TECHNOLOGY

KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium

KORU Medical | October 05, 2022

KORU Medical Systems, Inc. a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, announced its membership in the Subcutaneous (SC) Drug Development & Delivery Consortium making it one of the first device companies to be added to the Consortium. “The Consortium creates an important forum to identify and address key challenges and opportunities across the SC field. Key industry experts can collaborate on issues at the clinical, regulatory, and commercial level and work towards advancing the SC market and creating the best outcomes for patients. I am excited for KORU Medical’s membership as one of the first device companies and look forward to advancing SC drug delivery.” Linda Tharby, KORU Medical’s President and CEO The Consortium was convened in 2018 as a community of well-recognized industry experts with decades of experience in the pharmaceutical drug delivery, device development, and commercialization space. The Consortium was built upon a strong desire for clear and transparent evidence-based communication of existing SC technologies and information. The Consortium’s mission is to identify current and future unmet medical needs within a dynamic SC drug delivery and development environment to transform patient care and improve patient outcomes. As a member, KORU Medical will contribute to advancing understanding of patient preference for SC therapy and the clinical trial strategy and technology for high-volume SC drugs. KORU Medical was one of the first companies to develop technology for SC biologics with volumes above 5mL, and its Freedom System is used by over 25,000 patients today to receive SC therapy. KORU Medical is established as the market leader in above 10mL and will bring this deep expertise in patient experience and subcutaneous injection technology to the Consortium. About KORU Medical KORU Medical develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (the “Freedom System”) currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings.

Read More

HEALTH TECHNOLOGY

Inbound Health Launches to Enable Partners to Build and Scale Hospital and Skilled Nursing Facility-at-Home Care Models

Allina Health and Flare Capital Partners | October 19, 2022

Allina Health and Flare Capital Partners announced the launch of Inbound Health, a new company that enables health systems and health plans to offer hospital-at-home and skilled nursing-at-home programs. These innovative new care models create the ability to care for patients requiring facility-level acute or post-acute care in their home, thereby improving patient access, satisfaction, and outcomes while lowering total cost of care. Inbound Health provides the full stack of capabilities that are required to scale at-home care models including home-based care pathways, virtual care teams, engagement and workflow technology, analytics, supply chain partnerships, operational oversight and payment models. The company's flexible partnership structure enables customers to leverage their existing assets and capabilities while relying on Inbound Health to fill the gaps required to scale these programs across their service area To date, more than 4,200 patients across 185 primary diagnoses have been cared for through the Inbound Health platform, which has been operational in Allina Health’s service area since May 2020. The program has allowed Allina Health to manage a wider swath of the continuum of care for its patients, thereby ensuring that care is delivered in a safe, coordinated and patient-centric manner. The company combines biometric monitoring, digital surveillance, in-home nursing and therapy, virtual visits with hospitalists and geriatricians, and a comprehensive supply chain to deliver a safe and high-quality care program. Inbound Health has proven that the program lowers total-cost-of-care by 30-40% on a risk-adjusted basis while achieving similar or improved clinical outcomes when compared to traditional facility-based care. These outcomes have enabled Inbound Health and Allina to develop unique episodic-based payer contracts with multiple Commercial and Medicare Advantage payers in Minnesota, a payment model that the company plans on replicating with partners in other markets. “The home hospital programs that we’ve scaled to thousands of patients here in Minnesota are rooted in our Population Health drivers of delivering safe, high quality, affordable care that’s timely and convenient to access. We are excited for Inbound Health to leverage the capabilities and know-how that power these programs to scale similar at-home programs across the nation.” Lisa Shannon, President and CEO of Allina Health Inbound Health will be led by CEO Dave Kerwar who brings a 20-year track record of executing leading-edge strategies to improve care quality, reduce cost, and create consumer-centricity in healthcare. Previously, Dave was the Chief Product Officer at Mount Sinai Health System where he built innovative technology-enabled operations to scale direct-to-consumer, direct-to-employer, and population health programs. Prior to Mount Sinai, Dave led business development for Aetna’s Joint Ventures where he launched Provider Owned Health Plans with leading health systems across the country. “We are proud to be backed by one of the most prestigious health systems and one of the largest dedicated healthcare technology venture capital firms in the country in our pursuit to revolutionize this new level of care,” said Dave Kerwar. “Inbound Health will leverage the clinical, operational, and technology assets that we’ve developed alongside Allina Health to enable our customers nationwide to safely offer facility-level care in the home, at a lower cost and with an elevated patient and caregiver experience.” Inbound Health will use the new financing to continue to advance its proprietary technology platform that integrates with a variety of biometric monitoring devices and brings forward engagement, workflow, and AI-powered analytic capabilities that are purpose-built to scale these at-home care programs. This platform optimizes Inbound Health’s ability to perform key functions on behalf of its partners, including: “Home-based acute care models represent a compelling opportunity to lower the cost of care while increasing access and satisfaction for patients,” said Michael Greeley, Co-founder and General Partner, Flare Capital Partners. “Inbound Health is truly differentiated, not only due to the unique clinical and technology assets that underpin the platform, but also because it has powered one of the largest hospitals and SNF-at-home programs in the country. We look forward to partnering with Dave and the Inbound Health team to scale this platform nationally.” About Allina Health Allina Health is dedicated to the prevention and treatment of illness and enhancing the greater health of individuals, families and communities throughout Minnesota and western Wisconsin. A not-for-profit health care system, Allina Health cares for patients from beginning to end-of-life through its 90+ clinics, 12 hospitals, 14 retail pharmacies, specialty care centers and specialty medical services that provide home care, senior transitions, hospice care, home oxygen and medical equipment, and emergency medical transportation services. About Flare Capital Partners Flare Capital Partners strives to help build significant healthcare technology, digital health, and healthcare services companies to improve health outcomes and broaden access while lowering costs of care. We partner with inspirational entrepreneurs who seek to transform the business of healthcare by developing innovative and impactful products and services. Flare Capital is a team of proven healthcare technology investors and senior operating executives known for thought leadership and unparalleled strategic industry resources. Our firm has raised some of the industry’s largest dedicated venture capital funds focused on early-stage opportunities in healthcare technology innovation, and our investors include leading healthcare companies, major institutional investors, important family offices, foundations, and sovereign wealth funds. We are full life-cycle investors in our portfolio companies as we work alongside entrepreneurs over their entire company-building journey. Select portfolio companies include Aetion, Aspen RxHealth, Bright Heath, Cayaba Care, Cohere Health, Eden Health, HealthVerity, Inbound Health, Iora Health, Oshi Health, Somatus, and VisitPay. The firm has developed the very successful Flare Scholar program with over 250 participants and actively leverages its extended industry network, Executive Partners, and Industry Advisory Board for the benefit of the entrepreneurs and founders with whom it is privileged to partner.

Read More